A comprehensive regulatory model to ensure safety and quality of medical devices

Announcing a new article publication for BIO Integration journal. The development of a comprehensive regulatory model for medical devices is essential to ensure the safety, efficacy, and quality of medical devices throughout their lifecycle, from design and development to post-market surveillance.

High-Strength Wegovy; Aldosteronism Outcome Definitions; Insulin Unit Price Down 42%

Patients treated with semaglutide 7.2 mg achieved a 20.7% weight loss after 72 weeks compared with a reduction of 17.5% with semaglutide 2.4 mg (Wegovy)

January 22, 2025

Proposed rule would make hospital prices even more transparent

“How much is the ice cream?” A simple enough question, featured on a new TV and online advertisement, posed by a man who just wants

August 14, 2023

FDA Warns of Overdoses With Compounded Semaglutide

Overdoses, some even requiring hospitalization, have occurred due to patient and physician confusion around compounded semaglutide, the FDA detailed in an alert. Adverse events reported

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.